The Current Anti-TB Drug Research and Development Pipeline
This report discusses compounds with potential for the treatment of TB and categorizes them into the discovery, preclinical, or clinical phases of development.
This report discusses compounds with potential for the treatment of TB and categorizes them into the discovery, preclinical, or clinical phases of development.
This resource presents a method of assessing and updating laboratory procedures to assist in detecting TB early by reducing lab turnaround time for reporting positive smear, culture, identification, and susceptibility results.
This report presents a regional framework for addressing TB/HIV co-infection in the Western Pacific that is adapted to the epidemiological profile and health service system of the region and identifies areas in which both programs can complement each other to address TB/HIV.
This wall chart illustrates the key steps in administration and reading of the TB skin test, and describes the cutpoints for interpretation of the skin test. Dimensions: 24 1/4 x 27 1/2 in.
This book presents the objectives of the binational agenda for the Healthy Border 2010 program which was designed to facilitate and support community-based solutions for health promotion, disease prevention, and access to health services in the border region.
This report assesses the effectiveness, cost, and cost-effectiveness of the public-private mix DOTS (PPM-DOTS) program in pilot projects in Hyderabad and Delhi, India.
This guideline promotes collaboration between TB and HIV/AIDS programs to reduce the burden for people affected by both diseases.
This guide is designed to help health care workers working in low-income countries interpret chest radiographs of children with suspected TB in areas where there is limited access to a radiologist or specialist.
This report provides suggestions that may facilitate increased involvement of the National Tuberculosis Control Program (NTP) in health sector reform, encourage increased technical input into health systems' planning, and promote the strategic positioning of TB control in the context of changing health systems.
This book presents five papers that were used as background to a workshop on "Improving TB Drug Management: Accelerating DOTS Expansion" on June 2002, in Washington, DC. The papers address the weaknesses in drug management programs of certain countries and provide a framework for strengthening these programs through country-specific action plans.